Literature DB >> 18597154

An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for rheumatoid arthritis.

N Bellamy1, C Anjema, T S Frankovic, N Horowitz, G C Mills, S Shulman, C Smith, J Hill, J Campbell.   

Abstract

AIMS: A study was designed to assess the effects of a standardized instructional videotape on training senior medical students to acceptable levels of reliability in performing several commonly used observer dependent outcome measures in patients with rheumatoid arthritis (RA).
METHODS: During a single day, six third-year medical students independently examined six patients with RA in predetermined order using a Latin Square design, before and after viewing a standardized videotape demonstrating 15 examination techniques. Reliability coefficients were calculated based on the variance components of the analysis of variance (ANOVA) table.
RESULTS: Prestandardization reliability coefficients were >0.80 for all measures and remained above 0.80 following standardization except for one measure.
CONCLUSIONS: High levels of interobserver agreement were noted prior to viewing the instructional videotape. This may represent the success of undergraduate clinical skills training programmes or it may be me result of the students having reviewed an illustrated instructional text just prior to the initial patient examinations. High levels of prestandardization reliability, by necessity, precluded the demonstration of significant effects from viewing the videotape. Nevertheless, the data indicate that senior medical students are capable of reliably performing quantitative measurement in RA. Recent surveys in Canada and Australia, showing a general lack of quantitative clinical measurement in the longitudinal follow up of RA outpatients by rheumatologists, suggest that the lack of standardization is not due to inability to reliably perform the measurements.

Entities:  

Year:  1999        PMID: 18597154     DOI: 10.1007/BF02918385

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  20 in total

1.  Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.

Authors:  N Bellamy; S Carette; P M Ford; W F Kean; N G le Riche; A Lussier; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

2.  An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for fibromyalgia.

Authors:  N Bellamy; C Anjema; T Chhina; N Dudek; B Hurley; B Landesman; L Probyn; J Hill; J Campbell
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

3.  Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada.

Authors:  N Bellamy; S Kaloni; J Pope; K Coulter; J Campbell
Journal:  J Rheumatol       Date:  1998-05       Impact factor: 4.666

4.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche
Journal:  Control Clin Trials       Date:  1989-03

5.  A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability.

Authors:  S Green; R Buchbinder; A Forbes; N Bellamy
Journal:  Arthritis Care Res       Date:  1998-02

6.  Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Authors:  N Bellamy; W W Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

7.  Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Authors:  N Bellamy; T P Anastassiades; W W Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

8.  An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for ankylosing spondylitis.

Authors:  N Bellamy; C Anjema; D Dhanoa; A Joglekar; G C Mills; G Nesrallah; C Smith; C Ucar; J Hill; J Campbell
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

9.  Ankylosing spondylitis antirheumatic drug trials: Effects of a standardized instructional viddeotape on the reliability of observer-dependent outcome measures.

Authors:  N Bellamy; K D Muirden; K Boyden; G McColl; H Moran; A Stockman; M M Tellus; I Wicks; J Campbell
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

10.  Rheumatoid arthritis antirheumatic drug trials: effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures.

Authors:  N Bellamy; K D Muirden; A Bendrups; K Boyden; G McColl; H Moran; A Stockman; M M Tellus; R Travers; J Campbell
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

View more
  3 in total

1.  An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for fibromyalgia.

Authors:  N Bellamy; C Anjema; T Chhina; N Dudek; B Hurley; B Landesman; L Probyn; J Hill; J Campbell
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

2.  An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for osteoarthritis.

Authors:  N Bellamy; C Anjema; N Alikhan; T Chhina; D Dhanoa; D Edelist; Z Esufali; F Ismail; J Hill; J Campbell
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

Review 3.  Towards a conceptual framework demonstrating the effectiveness of audiovisual patient descriptions (patient video cases): a review of the current literature.

Authors:  Damian Roland; Tim Coats; David Matheson
Journal:  BMC Med Educ       Date:  2012-12-21       Impact factor: 2.463

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.